DIFFERENT PATTERNS OF HUMAN PORPHYRIA.

Suppr

超能文献

作者信息

WITH T K

出版信息

Br Med J. 1963 Oct 26;2(5364):1065-6. doi: 10.1136/bmj.2.5364.1065-a.

DOI:10.1136/bmj.2.5364.1065-a

PMID:14059423

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1873143/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc97/1873143/baaed0b630b7/brmedj02521-0094-a.jpg

相似文献

DIFFERENT PATTERNS OF HUMAN PORPHYRIA.

Br Med J. 1963 Oct 26;2(5364):1065-6. doi: 10.1136/bmj.2.5364.1065-a.

Dual porphyrias revisited.

Exp Dermatol. 2006 Sep;15(9):685-91. doi: 10.1111/j.1600-0625.2006.00464.x.

Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.

Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):867-76.

[Diagnosis and therapy of hepatic porphyria].

Acta Med Austriaca. 1990;17(5):94-9.

The cutaneous porphyrias.

Dermatol Clin. 2014 Jul;32(3):369-84, ix. doi: 10.1016/j.det.2014.03.001. Epub 2014 May 5.

Cutaneous Porphyrias: Causes, Symptoms, Treatments and the Danish Incidence 1989-2013.

Acta Derm Venereol. 2016 Nov 2;96(7):868-872. doi: 10.2340/00015555-2444.

[Treatment of the porphyrias].

Nihon Rinsho. 1995 Jun;53(6):1456-62.

Molecular mechanisms of dominant expression in porphyria.

J Inherit Metab Dis. 2005;28(3):277-86. doi: 10.1007/s10545-005-8050-3.

[Treatment of acute porphyrias. The importance of follow-up of patients and carriers].

Orv Hetil. 2003 May 11;144(19):933-8.

[Acute hepatic porphyria and its neurological syndrome].

Schweiz Med Wochenschr. 1996 Jan 9;126(1-2):6-14.

本文引用的文献

[Familial, non-spherocytic hemolytic anemia with excretion of porphyrin precursors].

Helv Paediatr Acta. 1961 Jun;16:111-33.

Excretion of porphobilinogen and 5-aminolaevulinic acid in acute porphyria.

Lancet. 1961 Jun 10;1(7189):1256-60. doi: 10.1016/s0140-6736(61)92764-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

DIFFERENT PATTERNS OF HUMAN PORPHYRIA.

Br Med J. 1963 Oct 26;2(5364):1065-6. doi: 10.1136/bmj.2.5364.1065-a.

Dual porphyrias revisited.

Exp Dermatol. 2006 Sep;15(9):685-91. doi: 10.1111/j.1600-0625.2006.00464.x.

Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.

Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):867-76.

[Diagnosis and therapy of hepatic porphyria].

Acta Med Austriaca. 1990;17(5):94-9.

The cutaneous porphyrias.

Dermatol Clin. 2014 Jul;32(3):369-84, ix. doi: 10.1016/j.det.2014.03.001. Epub 2014 May 5.

Cutaneous Porphyrias: Causes, Symptoms, Treatments and the Danish Incidence 1989-2013.

Acta Derm Venereol. 2016 Nov 2;96(7):868-872. doi: 10.2340/00015555-2444.

[Treatment of the porphyrias].

Nihon Rinsho. 1995 Jun;53(6):1456-62.

Molecular mechanisms of dominant expression in porphyria.

J Inherit Metab Dis. 2005;28(3):277-86. doi: 10.1007/s10545-005-8050-3.

[Treatment of acute porphyrias. The importance of follow-up of patients and carriers].

Orv Hetil. 2003 May 11;144(19):933-8.

[Acute hepatic porphyria and its neurological syndrome].

Schweiz Med Wochenschr. 1996 Jan 9;126(1-2):6-14.

本文引用的文献

[Familial, non-spherocytic hemolytic anemia with excretion of porphyrin precursors].

Helv Paediatr Acta. 1961 Jun;16:111-33.

Excretion of porphobilinogen and 5-aminolaevulinic acid in acute porphyria.

Lancet. 1961 Jun 10;1(7189):1256-60. doi: 10.1016/s0140-6736(61)92764-7.